| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.088 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |